MedTech Dive February 26, 2024
After the transaction’s expected close in the first half of this year, Agiliti will no longer trade on the New York Stock Exchange.
Medical technology services provider Agiliti said Monday it has agreed to be acquired by private equity firm Thomas H. Lee Partners (THL), its majority shareholder, in a deal valued at about $2.5 billion.
An affiliate of THL will buy all outstanding Agiliti common stock that it does not currently own for $10 per share in cash, representing a premium of 39% over Agiliti’s 30-day, volume-weighted average share price through Friday, the companies said.
The deal is expected to close in the first half of 2024, after which Agiliti will become a private company.
“We are pleased to...
Today's Sponsors
Today's Sponsor